Skip to main content
. 2016 Mar 3;7(15):20041–20053. doi: 10.18632/oncotarget.7884

Figure 6. Clinical associations of miR-432 with E2F3 and AXL expression.

Figure 6

(A) The percentage of specimens showing low or high miR-32 expression in relation to the expression levels of E2F3 and AXL; *p < 0.05. (B) Two representative cases are shown.